|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||1,992.05 - 2,031.30|
|52 Week Range||1,901.65 - 3,394.95|
|PE Ratio (TTM)||17.18|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Categories: Yahoo FinanceGet free summary analysis Dr. Reddy’s Laboratories Ltd. reports financial results for the quarter ended March 31, 2017. Highlights Summary numbers: Revenues of INR 35542 million, Net Earnings of INR 3125 million. Gross margins narrowed from 56.64% to 47.68% compared to the same period last year, operating (EBITDA) margins now 15.44% from 20.76%. Earnings growth ... Read more (Read more...)
Dr. Reddy's Laboratories Ltd.'s (RDY) first-quarter fiscal 2018 earnings per American Depositary Share (ADS) declined year over year while sales increased from the year ago quarter.
On a per-share basis, the Hyderabad, India-based company said it had net income of 6 cents. The pharmaceutical posted revenue of $513 million in the period. Doctor Reddy's shares have dropped 15 percent ...